P-Cresol

P-Cresol

SCHEMBL29107236

CC(C)(C)OC(N)=O.Cc1ccc(O)cc1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.50
▸ MIF P14174 1/20 0.41
▸ MAPT P10636 3/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ CA2 P00918 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ GAA P10253 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ GPR119 Q8TDV5 1/20 0.37
▸ BLM P54132 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ PARP10 Q53GL7 2/20 0.37
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ ESR1 P03372 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27647920 0.83 POLB (0.49) MAPTRAB9AALDH1A1NPC1POLB
SCHEMBL27510738 0.83 GPR119 (0.36) RAB9AALDH1A1GPR119KMT2APARP10
Toluene SCHEMBL26697033 0.82 TSHR (0.44) ACHEMAPTRAB9AALDH1A1NPC1
SCHEMBL27749283 0.80 GRM6 (0.44) ACHEMAPTNPC1CA2MAOA
P-Cresol SCHEMBL27906904 0.79 ACHE (0.72) ACHEMAPTRAB9AALDH1A1NPC1
SCHEMBL28902273 0.76 DGAT1 (0.42) ALDH1A1CA2MAOAMAOBBLM
SCHEMBL28325001 0.76 DGAT1 (0.42) ALDH1A1CA2MAOAMAOBBLM
SCHEMBL3094 0.76 — —
SCHEMBL30234788 0.76 DGAT1 (0.42) ALDH1A1CA2MAOAMAOBBLM
Bromide SCHEMBL28788279 0.75 CA12 (0.47) MAPTCA2GPR119KMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111971038-B Compositions and methods for dual targeted treatment of neuroendocrine tumors 纳米药业有限责任公司 2023-11-17 — — CN disclosed
CN-111971038-A Compositions and methods for dual-targeted treatment of neuroendocrine tumors 纳米药业有限责任公司 2020-11-20 — — CN disclosed
Send feedback